Pharmacokinetics of diazepam in the dog. 1981

W Löscher, and H H Frey

After i.v. administration of 2 mg/kg diazepam to dogs, concentrations of unmetabolized drug showed a triexponential decline with an average elimination half-life t0.5(beta) of 3.2 hr. Desmethyldiazepam appeared rapidly in plasma and exceeded diazepam concentrations by far. Elimination half-lives of this metabolite averaged 3.6 hr. Oxazepam reached maximal plasma concentrations in the range of 100 ng/ml after about 2 hr which then declined with a half-life of 5.7 hr. When the sum of the concentrations of diazepam and its active metabolites was plotted against time, the curve could be fitted by an open 2-compartment model, so that one of the apparent 3 compartments in the distribution of diazepam must be assumed to represent first pass demethylation to desmethyldiazepam. After oral administration of the same dose, desmethyldiazepam concentrations exceeded those of diazepam from the first blood sample taken. The share of unmetabolized diazepam in the total area under curve was only 1-3% after oral administration, but 7-21% after i.v. administration. Oral bioavailability was in the range of 74-100%. By continued oral administration of 1 or 2 mg/kg diazepam t.i.d. it was possible to maintain steady state plasma concentrations of 1000-2000 ng/ml desmethyldiazepam and maximal diazepam concentrations of 100-800 ng/ml. Oxazepam did not exceed a concentration of 100-200 ng/ml and small concentrations of 3-hydroxydiazepam could also be detected in these experiments. There was no indication of enzyme induction by this dose regimen. Both diazepam and desmethyldiazepam rapidly passed the blood/CSF barrier and reached steady state concentrations is CSF corresponding to the part not bound to serum proteins.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes

Related Publications

W Löscher, and H H Frey
October 1976, The Journal of pharmacology and experimental therapeutics,
W Löscher, and H H Frey
January 1978, Clinical pharmacokinetics,
W Löscher, and H H Frey
March 1985, Lancet (London, England),
W Löscher, and H H Frey
January 1974, Naunyn-Schmiedeberg's archives of pharmacology,
W Löscher, and H H Frey
March 1984, Journal of pharmaceutical sciences,
W Löscher, and H H Frey
June 1976, European journal of clinical pharmacology,
W Löscher, and H H Frey
September 1981, American journal of veterinary research,
W Löscher, and H H Frey
February 1996, Journal of veterinary pharmacology and therapeutics,
W Löscher, and H H Frey
September 1987, Journal of veterinary pharmacology and therapeutics,
W Löscher, and H H Frey
January 1980, Arzneimittel-Forschung,
Copied contents to your clipboard!